Society for Maternal-Fetal Medicine 2015

A recent article in the Boston Globe presents a disturbing picture of prenatal testing, in a report describing how “Oversold prenatal tests spur some to choose abortions.” The article goes on to discuss prenatal screening with cell free DNA, and to present a number of patient cases in which the screening test indicated that a patient was at high risk for aneuploidy when in fact, the fetus was normal.